DXTR - Dextera Surgical Inc.

Other OTC - Other OTC Delayed price. Currency in USD
0.038
0.000 (0.000%)
At close: 3:54PM EDT
Stock chart is not supported by your current browser
Previous close0.038
Open0.000
Bid0.000 x 0
Ask0.000 x 0
Day's range0.000 - 0.000
52-week range
Volume0
Avg. volume239,526
Market cap1.832M
Beta-2.93
PE ratio (TTM)N/A
EPS (TTM)-1.333
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est0.70
Trade prices are not sourced from all markets
  • Business Wire3 months ago

    Dextera Surgical Obtains Approval for Asset Sale to Aesculap, Inc.

    Dextera Surgical Inc. , a company developing and commercializing the MicroCutter 5/80™ Stapler, today announced that it had obtained approval by the Bankruptcy Court for the sale of substantially all of Dextera Surgical’s assets to Aesculap, Inc., a B.

  • Business Wire4 months ago

    Dextera Surgical Files for Chapter 11 Bankruptcy and Signs Asset Purchase Agreement With Aesculap, Inc.

    Dextera Surgical Inc. , a company developing and commercializing the MicroCutter 5/80™ Stapler, today announced that it has filed for voluntary Chapter 11 bankruptcy protection.

  • Business Wire5 months ago

    Dextera Surgical Reports Fiscal 2018 First Quarter Financial Results

    Dextera Surgical Inc. , a company developing and commercializing the MicroCutter 5/80™ Stapler, today announced financial results for its fiscal first quarter ended September 30, 2017.

  • Business Wire6 months ago

    Dextera Surgical to Cancel Fiscal 2018 First Quarter Financial Results Conference Call on Thursday November 9, 2017

    Dextera Surgical Inc. , a company commercializing and developing the MicroCutter 5/80™ Stapler, today announced that it plans to release its fiscal 2018 first quarter financial results after the markets close on November 9, 2017, and will file its 10-Q with the SEC within the required timeframe.

  • Business Wire6 months ago

    Dextera Surgical to Announce Fiscal 2018 First Quarter Financial Results on Thursday November 9, 2017

    Dextera Surgical Inc. , a company commercializing and developing the MicroCutter 5/80™ Stapler, today announced that it will release financial results for its fiscal 2018 first quarter ended September 30, 2017, on Thursday, November 9, 2017, after the markets close.

  • Business Wire7 months ago

    Dextera Surgical’s MicroCutter 5/80™ and Cardiac Anastomotic Devices to Be Featured at the 31st Annual European Association for Cardio-Thoracic Surgery

    Dextera Surgical Inc. , a company developing and commercializing the MicroCutter 5/80™ Stapler, today announced that several leading surgeons will feature the use of Dextera Surgical’s MicroCutter 5/80™ Stapler and its C-Port® Distal Anastomosis Systems in three oral presentations at the 31st Annual European Association for Cardio-Thoracic Surgery.

  • Business Wire7 months ago

    Dextera Surgical’s MicroCutter 5/80™ and Cardiac Anastomotic Devices to Be Featured at the 31st Annual European Association for Cardio-Thoracic Surgery

    Dextera Surgical Inc. (Nasdaq: DXTR), a company developing and commercializing the MicroCutter 5/80™ Stapler, today announced that several leading surgeons will feature the use of Dextera Surgical’s MicroCutter 5/80™ Stapler and its C-Port® Distal Anastomosis Systems in three oral presentations at the 31st Annual European Association for Cardio-Thoracic Surgery. “We are extremely pleased to have both the MicroCutter and the C-Port Systems highlighted in key presentations at EACTS, the largest cardiothoracic surgery meeting in the world,” said Liam Burns, vice president global sales and marketing of Dextera Surgical. Davor Stamenovic, M.D., of St. Vincentius Hospital in Karlsruhe, Germany will give two oral presentations highlighting the uses of the Microcutter 5/80 during single-port video-assisted thoracic surgery (VATS) procedures.

  • Business Wire7 months ago

    Dextera Surgical Provides Corporate Update

    Dextera Surgical Inc. , a company developing and commercializing the MicroCutter 5/80™ Stapler, today announced that revenue for the third quarter of fiscal 2018 will be approximately $568,000, with a current backorder of approximately $178,000 for MicroCutter Staplers and reloads.

  • Business Wire7 months ago

    Dextera Surgical Hosts Hands-on Training Course for Video-Assisted Thoracic Surgery Techniques Using MicroCutter 5/80™ for Segmentectomy

    Dextera Surgical Inc. (Nasdaq: DXTR), a company developing and commercializing the MicroCutter 5/80™ Stapler, today announced that it sponsored an international hands-on training course for thoracic surgeons from across Europe focused on advanced techniques for video-assisted thoracic surgery (VATS). During this day-long event in Tubingen, Germany, a faculty of world-leading thoracic surgeons taught advanced techniques which included the use of the MicroCutter 5/80™ in VATS for anatomical segmentectomy procedures. A segmentectomy is a procedure that removes a portion of a lobe of the lungs (typically comprised of two or more segments) rather than the entire lobe.

  • Business Wire10 months ago

    Dextera Surgical’s MicroCutter 5/80™ and Cardiac Anastomosis Devices Featured at International Society for Minimally Invasive Cardiothoracic Surgery Conference

    Dextera Surgical Inc. (Nasdaq: DXTR), a company developing and commercializing the Dextera MicroCutter 5/80™ Stapler, today announced that several leading surgeons highlighted the use of Dextera’s C-Port® Distal and PAS-Port® Proximal Anastomosis Systems as well as the MicroCutter 5/80 Stapler in a variety of less invasive surgical procedure presentations at the 14th Annual International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) meeting, held in Rome, Italy. “Dextera’s complete product line was featured in several presentations at the ISMICS meeting this year, showcasing the ability of our products to help enable less invasive cardiothoracic surgical procedures to improve patient outcomes,” said Julian Nikolchev, president and CEO of Dextera Surgical.

By using Yahoo you agree that Yahoo and partners may use Cookies for personalisation and other purposes